{
    "Trade/Device Name(s)": [
        "ADVIA Centaur TSH3-Ultra"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K150403",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083844"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JLW"
    ],
    "Summary Letter Date": "February 16, 2015",
    "Summary Letter Received Date": "February 18, 2015",
    "Submission Date": "April 24, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1690"
    ],
    "Regulation Name(s)": [
        "Thyroid stimulating hormone test system"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Thyroid stimulating hormone (TSH)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Heparinized plasma",
        "EDTA plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur",
        "ADVIA Centaur XP"
    ],
    "Method(s)/Technology(ies)": [
        "Radioimmunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Centaur TSH3-Ultra assay updating pediatric reference intervals for TSH measurement",
    "Indications for Use Summary": "For in vitro diagnostic use in the quantitative determination of thyroid-stimulating hormone (TSH, thyrotropin) in serum, heparinized plasma, and EDTA plasma using ADVIA Centaur and ADVIA Centaur XP systems; used in diagnosis of thyroid or pituitary disorders",
    "fda_folder": "Clinical Chemistry"
}